TY - CHAP
T1 - Pharmaceutical policy in the Netherlands
T2 - From price regulation towards managed competition
AU - Boonen, LHHM (Lieke)
AU - van der Geest, Stephanie
AU - Schut, Erik
AU - Varkevisser, Marco
PY - 2010/3/25
Y1 - 2010/3/25
N2 - Purpose - To analyse the development of pharmaceutical policy in the Dutch market for outpatient prescription drugs since the early 1990s. Methodology - A literature review and document analysis is performed to examine the effects of pharmaceutical policy on the performance of the Dutch market for outpatient prescription drugs since the early 1990s. Findings - Government efforts to control prices of pharmaceuticals were effective in constraining prices of in-patent drugs, but had an opposite effect on the prices of generic drugs. The gradual transition towards managed competition - that particularly gained momentum after the introduction of the new universal health insurance scheme in 2006 - appears to be more effective in constraining prices of generic drugs than earlier government efforts to control these prices. Originality - Comparative analysis of the impact of price regulation and managed competition on generic drug prices in the Netherlands. Implications - Implications of the changing role of health insurers are discussed for the future market for prescription drugs and role of pharmacies in the Netherlands.
AB - Purpose - To analyse the development of pharmaceutical policy in the Dutch market for outpatient prescription drugs since the early 1990s. Methodology - A literature review and document analysis is performed to examine the effects of pharmaceutical policy on the performance of the Dutch market for outpatient prescription drugs since the early 1990s. Findings - Government efforts to control prices of pharmaceuticals were effective in constraining prices of in-patent drugs, but had an opposite effect on the prices of generic drugs. The gradual transition towards managed competition - that particularly gained momentum after the introduction of the new universal health insurance scheme in 2006 - appears to be more effective in constraining prices of generic drugs than earlier government efforts to control these prices. Originality - Comparative analysis of the impact of price regulation and managed competition on generic drug prices in the Netherlands. Implications - Implications of the changing role of health insurers are discussed for the future market for prescription drugs and role of pharmacies in the Netherlands.
UR - http://www.scopus.com/inward/record.url?scp=77955010190&partnerID=8YFLogxK
U2 - 10.1108/S0731-2199(2010)0000022006
DO - 10.1108/S0731-2199(2010)0000022006
M3 - Chapter
C2 - 20575228
SN - 9781849507165
T3 - Advances in Health Economics and Health Services Research
SP - 53
EP - 76
BT - Pharmaceutical Markets and Insurance Worldwide
A2 - Dor, Avi
CY - Bingley
ER -